Showing results (3701-3710 of 8,098) with videos related to
Sort By:
Pageof 810
Current Medicinal Chemistry|June 18, 2014
Effect of DNA repair deficiencies on the cytotoxicity of drugs used in cancer therapy - a reviewJosé Manuel Calderón-Montaño, Estefanía Burgos-Morón, Manuel Luis Orta, et al.Current Medicinal Chemistry|June 18, 2014
Statins as bioactive molecules to support bone regenerationSarah B Brittain, Shalini V Gohil, Lakshmi S NairCurrent Medicinal Chemistry|June 18, 2014
DNA binding mode of transition metal complexes, a relationship to tumor cell toxicityM Ashfaq, T Najam, S S A Shah, et al.Current Medicinal Chemistry|June 18, 2014
Boronic acid-based enzyme inhibitors: a review of recent progressH Fu, H Fang, Jie Sun, et al.Current Medicinal Chemistry|June 18, 2014
Salvianolic acid B inhibits atherogenesis of vascular cells through induction of Nrf2-dependent heme oxygenase-1Hyun Jung Lee, MiRan Seo, Eun Jig LeeCurrent Medicinal Chemistry|June 18, 2014
Oxidative stress, redox signaling and cancer chemoresistance: putting together the pieces of the puzzleVanessa Jacob Victorino, Luciana Pizzatti, Pamela Michelletti, et al.Current Medicinal Chemistry|February 11, 2015
Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting MoleculesCláudia M Deus, Gabriela L Santos, Rute Loureiro, et al.Current Medicinal Chemistry|February 11, 2015
NAD⁺/NADH metabolism and NAD⁺-dependent enzymes in cell death and ischemic brain injury: current advances and therapeutic implicationsYingxin Ma, Hui Nie, Heyu Chen, et al.Current Medicinal Chemistry|February 11, 2015
Investigation of potential inhibitors of chorismate-utilizing enzymesMarkéta Švarcová, Martin Krátký, Jarmila VinšovaCurrent Medicinal Chemistry|February 11, 2015
Hck inhibitors as potential therapeutic agents in cancer and HIV infectionF Musumeci, S Schenone, C Brullo, et al.Pageof 810